Othera Pharmaceuticals

About:

Othera Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on treatments for ophthalmic diseases.

Top Investors: Johnson & Johnson Development Corporation, NewSpring Ventures, Liberty Venture Partners

Description:

Othera Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on treatments for ophthalmic diseases. Its products include OT-551 for geographic atrophy/dry age-related macular degeneration; OT-730 a small molecule oculoselective beta-blocker for reducing the elevated intraocular pressure associated with glaucoma; and OT-440, a neuroprotectant for glaucoma. The company was founded in 2002 and is headquartered in Exton, Pennsylvania.

Total Funding Amount:

$23.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Conshohocken, Pennsylvania, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)othera.com

Founders:

David Joseph, Ghanshyam Patil, William Matier

Number of Employees:

11-50

Last Funding Date:

2009-08-04

IPO Status:

Private

Industries: